GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cormedix Inc (NAS:CRMD) » Definitions » E10

Cormedix (Cormedix) E10 : $-2.73 (As of Dec. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Cormedix E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Cormedix's adjusted earnings per share data for the three months ended in Dec. 2023 was $-0.260. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-2.73 for the trailing ten years ended in Dec. 2023.

During the past 3 years, the average E10 Growth Rate was 3.10% per year. During the past 5 years, the average E10 Growth Rate was 24.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Cormedix was 37.30% per year. The lowest was 3.10% per year. And the median was 23.40% per year.

As of today (2024-05-02), Cormedix's current stock price is $5.37. Cormedix's E10 for the quarter that ended in Dec. 2023 was $-2.73. Cormedix's Shiller PE Ratio of today is .


Cormedix E10 Historical Data

The historical data trend for Cormedix's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cormedix E10 Chart

Cormedix Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.64 -3.00 -2.92 -2.99 -2.73

Cormedix Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.99 -2.99 -2.94 -2.87 -2.73

Competitive Comparison of Cormedix's E10

For the Biotechnology subindustry, Cormedix's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cormedix's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cormedix's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Cormedix's Shiller PE Ratio falls into.



Cormedix E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Cormedix's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.26/129.4194*129.4194
=-0.260

Current CPI (Dec. 2023) = 129.4194.

Cormedix Quarterly Data

per share eps CPI Adj_EPS
201403 -4.350 99.695 -5.647
201406 -0.250 100.560 -0.322
201409 -1.150 100.428 -1.482
201412 -0.450 99.070 -0.588
201503 -1.150 99.621 -1.494
201506 -0.650 100.684 -0.836
201509 -0.700 100.392 -0.902
201512 -0.500 99.792 -0.648
201603 -0.550 100.470 -0.708
201606 -0.650 101.688 -0.827
201609 -1.150 101.861 -1.461
201612 -0.800 101.863 -1.016
201703 -0.950 102.862 -1.195
201706 -0.500 103.349 -0.626
201709 -0.850 104.136 -1.056
201712 -0.750 104.011 -0.933
201803 -0.680 105.290 -0.836
201806 -0.520 106.317 -0.633
201809 -0.540 106.507 -0.656
201812 0.100 105.998 0.122
201903 -0.220 107.251 -0.265
201906 -0.030 108.070 -0.036
201909 -1.350 108.329 -1.613
201912 -0.210 108.420 -0.251
202003 -0.210 108.902 -0.250
202006 -0.140 108.767 -0.167
202009 -0.220 109.815 -0.259
202012 -0.190 109.897 -0.224
202103 -0.200 111.754 -0.232
202106 -0.120 114.631 -0.135
202109 -0.220 115.734 -0.246
202112 -0.200 117.630 -0.220
202203 -0.180 121.301 -0.192
202206 -0.190 125.017 -0.197
202209 -0.170 125.227 -0.176
202212 -0.200 125.222 -0.207
202303 -0.240 127.348 -0.244
202306 -0.250 128.729 -0.251
202309 -0.170 129.860 -0.169
202312 -0.260 129.419 -0.260

Add all the adjusted EPS together and divide 10 will get our e10.


Cormedix  (NAS:CRMD) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Cormedix E10 Related Terms

Thank you for viewing the detailed overview of Cormedix's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Cormedix (Cormedix) Business Description

Traded in Other Exchanges
Address
300 Connell Drive, Suite 4200, Berkeley Heights, NJ, USA, 07922
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's primary focus is to develop its lead product candidate, DefenCath, for potential commercialization in the United States (U.S.) and other key markets.
Executives
Alan W Dunton director VICURON PHARMACEUTICALS INC, 455 S GULPH ROAD SUITE 305, KING OF PRUSSIA PA 19406
Erin Mistry officer: Chief Commercial Officer 300 CONNELL DRIVE, SUITE 4200, BERKELEY HEIGHTS NJ 07922
Joseph Todisco director, officer: Chief Executive Officer 400 CROSSING BOULEVARD, BRIDGEWATER NJ 08807
Myron Kaplan director C/O KLEINBERG, KAPLAN, WOLFF & COHEN, PC, 551 FIFTH AVENUE, 18TH FLOOR, NEW YORK NY 10176
Paulo F Costa director MACROGENICS, INC., ONE CORPORATE DRIVE, SOUTH SAN FRANCISCO CA 94080
Robert A Stewart director 360 MT. KEMBLE AVENUE, MORRISTOWN NJ 07960
Janet Dillione director ONE WAYSIDE ROAD, BURLINGTON MA 01803
Matthew T David officer: EVP, Chief Financial Officer 300 CONNELL DRIVE, SUITE 4200, BERKELEY HEIGHTS NJ 07922
Elizabeth Masson officer: EVP, Head of Clinical Ops. 400 CONNELL DRIVE, SUITE 5000, BERKELEY HEIGHTS NJ 07922
Thomas Nusbickel officer: EVP, Chief Commercial Officer 300 CONNELL DRIVE, SUITE 4200, BERKELEY HEIGHTS NJ 07922
Gregory Scott Duncan director 44 MILTON AVENUE, ALPHARETTA GA 30009
Steven W Lefkowitz director SIX HARRISON STREET, NEW YORK NY 10013
Mehmood Khan director 700 ANDERSON HILL ROAD, PURCHASE NY 10577
Armstrong Jr. John L. officer: Exec VP of Tech Operations C/O CORMEDIX INC., 1430 U.S. HIGHWAY 206, SUITE 200, BEDMINSTER NJ 07921
Khoso Baluch director, officer: Chief Executive Officer 1430 US HIGHWAY 206, SUITE 200, BEDMINSTER NJ 07921